Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity

Diabetes mellitus (DM) increases risk for pulmonary tuberculosis (TB) and adverse treatment outcomes. Systemic hyper-inflammation is characteristic in people with TB and concurrent DM (TBDM) at baseline, but the impact of TB treatment on this pattern has not been determined. We measured 17 plasma cy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Nathella Pavan, Fukutani, Kiyoshi F, Shruthi, Basavaradhya S, Alves, Thabata, Silveira-Mattos, Paulo S, Rocha, Michael S, West, Kim, Natarajan, Mohan, Viswanathan, Vijay, Babu, Subash, Andrade, Bruno B, Kornfeld, Hardy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2019
Materias:
Immunology and Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660216/
https://www.ncbi.nlm.nih.gov/pubmed/31271354
http://dx.doi.org/10.7554/eLife.46477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660216/
https://www.ncbi.nlm.nih.gov/pubmed/31271354
http://dx.doi.org/10.7554/eLife.46477

Ejemplares similares